Brad Raybold

Brad Raybold is an experienced clinical research professional with a strong background in oncology, currently serving as Director, Clinical Research Scientist for Oncology Solid Tumors at Genmab since October 2022. Prior roles include Director, Clinical Project Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson, Clinical Operations Lead at Bristol-Myers Squibb, and Senior Clinical Scientist at Merck. Additional experience includes positions as International Clinical Trial Manager at Novo Nordisk A/S, Expert Clinical Manager at Novartis, and Clinical Research Scientist at Merck. Educational credentials include a Master of Science in Cardiac Rehabilitation and Physiology from East Stroudsburg University of Pennsylvania and a Bachelor of Science in Kinesiology from Penn State University.